• 1
    Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873880.
  • 2
    Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 18451853.
  • 3
    Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 15391549.
  • 4
    Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 2006; 27: 26822688.
  • 5
    McAlister FA, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 2007; 297: 25022514.
  • 6
    Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004; 44: 18341840.
  • 7
    Yu CM, Bleeker GB, Fung JW, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005; 112: 15801586.
  • 8
    Di Biase L, Auricchio A, Sorgente A, et al. The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy. Eur Heart J 2008; 29(20): 24972505.
  • 9
    Hawkins NM, Petrie MC, MacDonald MR, et al. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? Eur Heart J 2006; 27: 12701281.
  • 10
    Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008; 117: 26082616.
  • 11
    Shimano M, Inden Y, Yoshida Y, et al. Does RV lead positioning provide additional benefit to cardiac resynchronization therapy in patients with advanced heart failure? Pacing Clin Electrophysiol 2006; 29: 10691074.
  • 12
    Shimano M, Tsuji Y, Yoshida Y, et al. Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block. Europace 2007; 9: 869874.
  • 13
    Parker JD, Landzberg JS, Bittl JA, et al. Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle. Circulation 1991; 84: 10401048.
  • 14
    Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999; 99: 15671573.
  • 15
    Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999; 99: 29933001.
  • 16
    Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002; 39: 194201.
  • 17
    Steendijk P, Tulner SA, Bax JJ, et al. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops. Circulation 2006; 113: 12951304.
  • 18
    Kass DA. An epidemic of dyssynchrony: but what does it mean? J Am Coll Cardiol 2008; 51: 1217.
  • 19
    Chalil S, Stegemann B, Muhyaldeen S, et al. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol 2007; 50: 243252.
  • 20
    Kolias TJ, Aaronson KD, Armstrong WF. Doppler-derived dP/dt and -dP/dt predict survival in congestive heart failure. J Am Coll Cardiol 2000; 36: 15941599.
  • 21
    Landolina M, Lunati M, Gasparini M, et al. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Am J Cardiol 2007; 100: 10071012.
  • 22
    Mottram PM, Marwick TH. Assessment of diastolic function: what the general cardiologist needs to know. Heart 2005; 91: 681695.
  • 23
    Oguz E, Dagdeviren B, Bilsel T, et al. Echocardiographic prediction of long-term response to biventricular pacemaker in severe heart failure. Eur J Heart Fail 2002; 4: 8390.
  • 24
    Sogaard P, Egeblad H, Kim WY, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002; 40: 723730.
  • 25
    Heist EK, Taub C, Fan D, et al. Usefulness of a novel “response score” to predict hemodynamic and clinical outcome from cardiac resynchronization therapy. Am J Cardiol 2006; 97: 17321736.
  • 26
    Tournoux FB, Alabiad C, Fan D, et al. Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome. Eur Heart J 2007; 28: 11431148.
  • 27
    Anderson LJ, Miyazaki C, Sutherland GR, et al. Patient selection and echocardiographic assessment of dyssynchrony in cardiac resynchronization therapy. Circulation 2008; 117: 20092023.
  • 28
    Gasparini M, Mantica M, Galimberti P, et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol 2003; 26: 175180.
  • 29
    Woo GW, Petersen-Stejskal S, Johnson JW, et al. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J Interv Card Electrophysiol 2005; 12: 107113.
  • 30
    Mangiavacchi M, Gasparini M, Faletra F, et al. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure. Am Heart J 2006; 151: 477.